10-K: DSwiss Inc. Reports Fiscal Year 2023 Results, Revenue Declines Amidst Strategic Shifts

DSwiss Inc. reported a decrease in revenue for the fiscal year 2023, alongside a net loss, while highlighting strategic initiatives in product development and market expansion.

Summary

• DSwiss Inc. reported a revenue of $1,470,071 for the year ended December 31, 2023, a decrease of 20.5% compared to $1,849,047 in 2022.
• The company's cost of revenue decreased to $1,110,846 in 2023 from $1,404,054 in 2022, aligning with the revenue decline.
• Gross profit decreased to $359,225 in 2023 from $444,993 in 2022, while the gross margin slightly increased to 24.18% from 24.06%.
• Operating expenses decreased to $367,647 in 2023 from $402,412 in 2022.
• The company recorded a net loss of $49,535 for 2023, compared to a net loss of $2,937 in 2022.
• The accumulated loss for the company increased to $1,410,153 by the end of 2023.
• The company had a working capital surplus of $21,848 as of December 31, 2023, with cash and cash equivalents of $249,110.
• Net cash generated from operating activities was $45,295 in 2023, compared to $22,428 in 2022.
• The company is actively seeking opportunities for mergers and acquisitions to enhance growth.

Sentiment

Score: 4

Explanation: The document presents a mixed picture with significant challenges. While there are some positives like increased cash from operations and strategic initiatives, the substantial revenue decline, increased net loss, and identified internal control weaknesses raise concerns. The overall sentiment is cautiously negative.

Positives

• The company's gross margin saw a slight increase, indicating improved cost management.
• Net cash generated from operating activities increased year-over-year, showing improved cash flow management.
• DSwiss is actively pursuing strategic initiatives such as market expansion and mergers and acquisitions.
• The company has a strong focus on research and development to maintain a competitive edge.

Negatives

• The company experienced a significant decrease in revenue, indicating potential challenges in sales.
• The net loss increased substantially year-over-year, raising concerns about profitability.
• The accumulated loss has grown to $1,410,153, highlighting the company's financial challenges.
• The company identified material weaknesses in its internal controls over financial reporting.

Risks

• The company faces competition in the beauty and healthcare industry, which may impact its market share.
• The company's ability to raise additional funds when required may have a negative impact on its operations.
• The company identified material weaknesses in its internal controls over financial reporting, which could lead to misstatements in financial reports.
• The company's reliance on social media for marketing may be affected by changes in social media trends or algorithms.
• The company's financial statements are prepared assuming it will continue as a going concern, but there is substantial doubt about its ability to do so.

Future Outlook

The company plans to expand its market share through social media and online e-commerce platforms, and is actively seeking merger and acquisition opportunities to enhance growth. They also intend to develop new formulas and products to maintain a competitive position in the market.

Management Comments

• The company's Chief Executive Officer, Vincent Leong, has led it with a strong hand, and as a result, our products are now consumed around the world.
• The management had decided to place a higher priority on social media for our marketing strategy.
• The management believe that organic growth itself is incapable of coping with the expectation of shareholders in the current dynamic business environment, thus via merger and acquisition the Company can create greater value to every stakeholder not limited to shareholders.

Industry Context

The beauty and healthcare industry is highly competitive, and DSwiss faces challenges from competitors with greater access to capital. The company is trying to differentiate itself through its focus on natural ingredients, quality control, and a one-stop service model. The company is also exploring functional medicine and homeopathic supplements to address complementary health and integrative health market needs.

Comparison to Industry Standards

• The company's revenue decline of 20.5% is a significant deviation from the growth trends seen in many parts of the health and beauty sector, where some companies have seen double-digit growth.
• The increase in net loss from $2,937 to $49,535 indicates a worsening financial performance compared to industry averages, where many companies are focused on profitability.
• The company's gross margin of 24.18% is relatively low compared to some of the larger players in the industry, who often achieve gross margins of 40% or higher.
• The company's focus on social media marketing aligns with industry trends, but its effectiveness needs to be improved to drive revenue growth.
• The company's active pursuit of mergers and acquisitions is a common strategy in the industry to achieve rapid growth and market share, but the success of these efforts will be critical.

Related Party Transactions

• The company had professional fees of $13,001 with a related party A in 2023.
• The company had sales of $48,366 with a related party C in 2023.

Stakeholder Impact

• Shareholders may be concerned about the decrease in revenue and the increase in net loss.
• Employees may be affected by the company's financial challenges and potential restructuring.
• Customers may be impacted by changes in product offerings or service quality.
• Suppliers may be affected by changes in the company's purchasing patterns or payment terms.
• Creditors may be concerned about the company's ability to repay its debts.

Next Steps

• The company plans to increase its market share through social media and online e-commerce platforms.
• The company intends to work closely with professional biotech and life sciences partners to strengthen its advantages.
• The company plans to work closely with new retail tech partners to increase sales and exposure.
• The company will continue to develop new formulas and products to maintain a competitive position in the market.
• The company is actively seeking merger and acquisition opportunities to drive growth.

Key Dates

Keywords

OEM, ODM, nutraceutical, skincare, beauty products, health products, biotech, manufacturing, private label, functional food